Significant developments have been made in mRNA therapy over the past several decades. Many monotherapies and combinations are in trial. Companies are diligently working toward the development of novel treatments. Key players such as BioNTech SE, ModernaTX, CureVac, Sanofi, and others are some of the major players that are going to boost the global mRNA-based vaccines and therapeutics market dynamics in the coming years..

在过去的几十年中，mRNA治疗取得了重大进展。许多单一疗法和联合疗法正在试验中。公司正在努力开发新的治疗方法。BioNTech SE、ModernaTX、CureVac、Sanofi等关键参与者是未来几年推动全球基于mRNA的疫苗和治疗剂市场动态的主要参与者。。

LAS VEGAS, Jan. 25, 2024 /PRNewswire/ -- DelveInsight's Global mRNA-based Vaccines and Therapeutics Market Insights report includes a comprehensive understanding of current treatment practices, emerging global mRNA-based vaccines and therapeutics, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan]..

拉斯维加斯，2024年1月25日/PRNewswire/--DelveInsight的全球基于mRNA的疫苗和治疗市场洞察报告包括对当前治疗实践，新兴的全球基于mRNA的疫苗和治疗方法，个体疗法的市场份额以及2019年至2032年的当前和预测市场规模的全面了解，分为7MM[美国、EU4（德国、法国、意大利和西班牙）、英国和日本]。。

Key Takeaways from the Global mRNA-based Vaccines and Therapeutics Market Report

全球基于mRNA的疫苗和治疗剂市场报告的主要收获

According to DelveInsight's analysis, the market size for global mRNA-based vaccines and therapeutics across the 7MM is expected to grow with a significant CAGR by 2032.

根据DelveInsight的分析，全球基于mRNA的疫苗和治疗剂的市场规模预计将在2032年以显着的复合年增长率增长。

According to the American Cancer Society (2023), in general, about 10–15% of all lung cancers are SCLC, and about 80–85% are NSCLC. In 2023, an estimated 238K adults (117K men and 120K women) in the United States will be diagnosed with lung cancer.

根据美国癌症协会（2023年）的数据，一般来说，大约10-15%的肺癌是小细胞肺癌，大约80-85%是非小细胞肺癌。2023年，美国估计将有238K名成年人（117000名男性和120K名女性）被诊断出患有肺癌。

Leading mRNA-based vaccines and therapeutics companies such as Vertex Pharmaceuticals Incorporated, ReCode Therapeutics, ModernaTX, Inc., Merck Sharp & Dohme LLC, Remix Therapeutics, Audentes Therapeutics, Pfizer, Sirnaomics, Phoenicis Therapeutics, Astellas Pharma US, Inc., Immorna Biotherapeutics, Inc., ICON plc, Sangamo Therapeutics, 2seventy bio, Hillhurst Biopharmaceuticals, Inc., Silence Therapeutics plc, STORM Therapeutics LTD, BioNTech SE, Agomab Therapeutics NV, Alnylam Pharmaceuticals, Janssen Pharmaceutica N.V., AstraZeneca, Ocugen, Merus N.V., Sanofi, Immunomic Therapeutics, and others are developing novel mRNA-based vaccines and therapeutics that can be available in the global mRNA-based vaccines and therapeutics market in the coming years..

领先的基于mRNA的疫苗和治疗公司，例如Vertex Pharmaceuticals Incorporated，ReCode therapeutics，ModernaTX，Inc.，Merck Sharp＆Dohme LLC，Remix therapeutics，Audentes therapeutics，Pfizer，Sirnaomics，Phoenicis therapeutics，Astellas Pharma US，Inc.，Immora Biotherapeutics，Inc.，ICON plc，Sangamo therapeutics，2seventy bio，Hillhurst Biopharmaceuticals，Inc。，沉默治疗公司、STORM Therapeutics LTD、BioNTech SE、Agomab Therapeutics NV、Alnylam Pharmaceuticals、Janssen Pharmaceutica N.V.、AstraZeneca、Ocugen、Merus N.V.、Sanofi、Immunomic Therapeutics等公司正在开发新的基于mRNA的疫苗和治疗剂，这些疫苗和治疗剂可在未来几年的全球基于mRNA的疫苗和治疗剂市场上获得。。

The promising global mRNA-based vaccines and therapeutics in the pipeline include VX-522, RCT1100, mRNA-4157, REM-422, scAAV9.U7.ACCA, PF-06651600, STP705, PTW-002 10, Enzalutamide, JCXH-221, BIVV003, bbT369, HBI-002, SLN124, STC-15, BNT112, AGMB-129, ALN-HSD, JNJ-55308942, AZD8701, BBV152, MCLA-158, SAR441000, ITI-1000, and others..

正在开发的有前途的全球基于mRNA的疫苗和疗法包括VX-522，RCT1100，mRNA-4157，REM-422，scAAV9.U7.ACCA，PF-06651600，STP705，PTW-002 10，Enzalutamide，JCXH-221，BIV003，bbT369，HBI-002，SLN124，STC-15，BNT112，AGMB-129，ALN-HSD，JNJ-55308942，AZD8701，BBV152，MCLA-158，SAR441000，ITI-1000等。。

Discover which therapies are expected to grab the major global mRNA-based vaccines and therapeutics market share @ Global mRNA-based Vaccines and Therapeutics Market Report

发现哪些疗法有望占据全球主要的基于mRNA的疫苗和治疗剂市场份额@全球基于mRNA的疫苗和治疗剂市场报告

Global mRNA-based Vaccines and Therapeutics Overview

全球基于mRNA的疫苗和治疗概述

Messenger RNA (mRNA) is a form of single-stranded ribonucleic acid generated through transcription from a DNA strand. It contains the essential coding information for protein synthesis, which undergoes further transcription and processing to yield functional proteins. The progression of mRNA-based therapeutics encompasses critical stages such as mRNA design, synthesis, mRNA encapsulation, pharmacodynamics, pharmacokinetics, safety assessments in both in vivo and in vitro settings, manufacturing, and clinical trials.

信使RNA（mRNA）是通过DNA链转录产生的单链核糖核酸的一种形式。它包含蛋白质合成的基本编码信息，该信息经过进一步的转录和加工以产生功能性蛋白质。基于mRNA的疗法的进展包括关键阶段，例如mRNA设计，合成，mRNA包封，药效学，药代动力学，体内和体外环境中的安全性评估，制造和临床试验。

The design and synthesis of mRNA stand out as pivotal stages in the development of mRNA-based medications. The therapeutic application of mRNA holds significant promise in addressing a diverse range of incurable diseases. Recent rapid advancements in biotechnology and molecular medicine have empowered the ability to produce nearly any functional protein or peptide within the human body by introducing mRNA as a vaccine or therapeutic agent.

mRNA的设计和合成是基于mRNA的药物开发的关键阶段。mRNA的治疗应用在解决各种不可治愈的疾病方面具有重大前景。最近生物技术和分子医学的快速发展赋予了通过引入mRNA作为疫苗或治疗剂在人体内产生几乎任何功能性蛋白质或肽的能力。

This burgeoning field of precision medicine holds considerable potential for preventing and treating numerous challenging or genetic diseases..

这一新兴的精准医学领域在预防和治疗许多具有挑战性或遗传性疾病方面具有相当大的潜力。。

Global mRNA-based Vaccines and Therapeutics Epidemiology Segmentation

全球基于mRNA的疫苗和治疗流行病学细分

The global mRNA-based vaccines and therapeutics epidemiology section provides insights into the historical and current global mRNA-based vaccines and therapeutics patient pool and forecasted trends for the 7MM. It helps recognize the causes of current and forecasted patient trends by exploring numerous studies and views of key opinion leaders..

全球基于mRNA的疫苗和治疗流行病学部分提供了对历史和当前全球基于mRNA的疫苗和治疗患者库的见解，以及7MM的预测趋势。通过探索大量研究和关键意见领袖的观点，它有助于识别当前和预测患者趋势的原因。。

The global mRNA-based vaccines and therapeutics market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

全球基于mRNA的疫苗和治疗剂市场报告提供了2019-2032年研究期间的流行病学分析，分为以下7MM：

Total Incident Cases of Shortlisted Indications for mRNA Therapy for Oncology

肿瘤mRNA治疗短名单适应症的总事件案例

Total Indication-wise Eligible Cases for mRNA Therapy for Oncology

肿瘤mRNA治疗的总适应症符合条件的病例

Indication-wise Treated Cases of mRNA Therapy for Oncology

肿瘤mRNA治疗的适应症治疗病例

Global mRNA-based Vaccines and Therapeutics Treatment Market

全球基于mRNA的疫苗和治疗市场

Immunotherapy represents a groundbreaking approach in the field of cancer treatment. The use of mRNA vaccines has become an appealing and potent method for immunotherapy against cancer due to their high effectiveness, specificity, adaptability, ability for rapid and large-scale development, cost-effective manufacturing potential, and safety.

免疫疗法代表了癌症治疗领域的一种开创性方法。由于其高效性，特异性，适应性，快速和大规模开发的能力，具有成本效益的制造潜力和安全性，mRNA疫苗的使用已成为一种有吸引力和有效的癌症免疫治疗方法。

Recent advancements in the design and delivery of mRNA vaccines have expedited their development and application in cancer treatment. Extensive research conducted in preclinical and clinical trials has paved the way for the swift progress of mRNA vaccines, particularly evident during the COVID-19 pandemic.

mRNA疫苗的设计和递送的最新进展加速了它们在癌症治疗中的开发和应用。在临床前和临床试验中进行的广泛研究为mRNA疫苗的快速发展铺平了道路，特别是在新型冠状病毒肺炎大流行期间。

These therapeutic cancer vaccines, based on mRNA, are well-received, and the inherent advantage of easy production, comparable to the best traditional vaccine manufacturing methods, positions mRNA vaccines as a promising avenue for cancer immunotherapy..

这些基于mRNA的治疗性癌症疫苗广受欢迎，与最佳的传统疫苗制造方法相比，易于生产的固有优势使mRNA疫苗成为癌症免疫治疗的有前途的途径。。

In 1996, the initial investigation of a cancer vaccine based on mRNA involved testing dendritic cells loaded with RNA in a laboratory setting. Since then, advancements in technology have enhanced the structure, stability, and delivery techniques of mRNA. Currently, numerous clinical trials are actively recruiting cancer patients to explore the efficacy of mRNA-based vaccine therapies.

1996年，基于mRNA的癌症疫苗的初步研究涉及在实验室环境中测试负载RNA的树突状细胞。从那时起，技术的进步增强了mRNA的结构，稳定性和递送技术。目前，许多临床试验正在积极招募癌症患者，以探索基于mRNA的疫苗疗法的功效。

The administration routes for mRNA vaccines encompass intradermal, subcutaneous, intranasal, intranodal, intramuscular, intratumoral, and intravenous delivery..

mRNA疫苗的给药途径包括皮内，皮下，鼻内，结节内，肌肉内，肿瘤内和静脉内递送。。

The majority of cancer vaccines based on mRNA focus on treating existing cancer rather than preventing it, necessitating multiple doses and a significant vaccine strength to elicit a response against tumors when used as the sole form of treatment. While standalone mRNA vaccines may prove effective in treating early-stage cancer or as an additional therapy, their success as a solitary treatment for advanced cancers seems improbable due to the formidable challenges posed by the highly immunosuppressive tumor microenvironment in such cases..

大多数基于mRNA的癌症疫苗侧重于治疗现有癌症而不是预防癌症，当用作唯一的治疗形式时，需要多剂量和显着的疫苗强度才能引发针对肿瘤的反应。虽然独立的mRNA疫苗可能被证明可有效治疗早期癌症或作为一种额外的治疗方法，但由于在这种情况下高度免疫抑制的肿瘤微环境所带来的巨大挑战，它们作为晚期癌症的单独治疗的成功似乎不太可能。。

To know more about mRNA-based vaccines and therapeutics, visit @ Global mRNA-based Vaccines and Therapeutics

要了解更多关于基于mRNA的疫苗和疗法的信息，请访问@Global mRNA-based vaccines and therapeutics

Pipeline mRNA-based Vaccines and Therapeutics and Key Companies

基于mRNA的管道疫苗和治疗剂以及关键公司

VX-522: Vertex Pharmaceuticals Incorporated

VX-522：Vertex Pharmaceuticals Incorporated公司

RCT1100: ReCode Therapeutics

RCT1100：重新编码疗法

mRNA-4157: ModernaTX, Inc./Merck Sharp & Dohme LLC

mRNA-4157:ModernaTX，股份有限公司/默克夏普和多姆有限责任公司

REM-422: Remix Therapeutics

REM-422:Remix Therapeutics

scAAV9.U7.ACCA: Audentes Therapeutics

scAAV9.U7.ACCA：Audentes Therapeutics

PF-06651600: Pfizer

PF-06651600：辉瑞

STP705: Sirnaomics

STP705：Sirnaomics

PTW-002 10: Phoenicis Therapeutics

PTW-002 10：腓尼基治疗学

Enzalutamide: Astellas Pharma US, Inc.

恩扎鲁他胺：美国阿斯特拉制药公司，股份有限公司。

JCXH-221: Immorna Biotherapeutics, Inc./ICON plc

JCXH-221：Immorna Biotherapeutics，Inc./ICON plc

BIVV003: Sangamo Therapeutics

BIV003:Sangamo Therapeutics公司

bbT369: 2seventy bio

bbT369:2seventy生物

HBI-002: Hillhurst Biopharmaceuticals, Inc.

HBI-002：Hillhurst Biopharmaceuticals，股份有限公司。

SLN124: Silence Therapeutics plc

SLN124：沉默治疗公司

STC-15: STORM Therapeutics LTD

STC-15：风暴治疗有限公司

BNT112: BioNTech SE

BNT112:BioNTech SE

AGMB-129: Agomab Therapeutics NV

AGMB-129:Agomab Therapeutics NV

ALN-HSD: Alnylam Pharmaceuticals

ALN-HSD:Alnylam Pharmaceuticals

JNJ-55308942: Janssen Pharmaceutica N.V.

JNJ-55308942:Janssen Pharmaceutica N.V。

AZD8701: AstraZeneca

AZD8701：阿斯利康

BBV152: Ocugen

BBV152：奥库根

MCLA-158: Merus N.V.

MCLA-158:Merus N.V。

SAR441000: Sanofi

SAR441000：赛诺菲

ITI-1000: Immunomic Therapeutics

ITI-1000：免疫治疗学

Learn more about the FDA-approved mRNA-based vaccines and therapeutics @ mRNA-based Vaccines and Therapeutics Analysis

了解更多有关FDA批准的基于mRNA的疫苗和疗法@基于mRNA的疫苗和疗法分析的信息

Global mRNA-based Vaccines and Therapeutics Market Dynamics

全球基于mRNA的疫苗和治疗剂市场动态

The dynamics of the global mRNA-based vaccines and therapeutics market are expected to change in the coming years. Several mRNA-based vaccine candidates currently in pre-clinical and clinical phases of development are poised to drive the mRNA-based vaccines and therapeutics market in upcoming years, as the field of mRNA-based therapeutics spans from protein replacement therapy and gene editing to vaccination, and continued advancements in mRNA formulation and delivery using different nanomaterials hold the potential to improve the wider use of mRNA for the treatment and prevention of infectious diseases and cancers..

全球基于mRNA的疫苗和治疗剂市场的动态预计将在未来几年发生变化。目前处于临床前和临床开发阶段的几种基于mRNA的候选疫苗有望在未来几年推动基于mRNA的疫苗和治疗市场，因为基于mRNA的治疗领域涵盖了蛋白质替代疗法和基因编辑以及疫苗接种，并且使用不同纳米材料在mRNA制备和递送方面的持续进步有可能改善mRNA在治疗和预防传染病和癌症方面的广泛应用。。

Furthermore, many potential therapies are being investigated for the treatment of various cancers, and it is safe to predict that the treatment space will significantly impact the global mRNA-based vaccines and therapeutics market during the forecast period. Moreover, the anticipated introduction of emerging therapies with improved efficacy and a further improvement in the diagnosis rate are expected to drive the growth of the global mRNA-based vaccines and therapeutics market in the 7MM..

此外，正在研究许多潜在的治疗方法来治疗各种癌症，可以安全地预测，在预测期内，治疗空间将对全球基于mRNA的疫苗和治疗剂市场产生重大影响。此外，预计将引入具有改进功效和进一步提高诊断率的新兴疗法，预计将推动全球基于mRNA的疫苗和治疗剂市场在7MM的增长。。

However several factors may impede the growth of the global mRNA-based vaccines and therapeutics market. The broader utilization of mRNA-based therapeutics remains constrained by the requirement for enhanced vectors or drug delivery systems, as advanced delivery systems are essential to address issues such as poor stability, cell targeting, and translational efficiency of naked mRNA.

然而，有几个因素可能会阻碍全球基于mRNA的疫苗和治疗剂市场的增长。基于mRNA的疗法的更广泛应用仍然受到对增强载体或药物递送系统的要求的限制，因为先进的递送系统对于解决诸如裸mRNA的稳定性差，细胞靶向和翻译效率等问题至关重要。

Consequently, challenges persist in the delivery of mRNA-based therapeutics, including technical obstacles that need to be overcome for the successful implementation of mRNA-based therapies..

因此，基于mRNA的疗法的提供仍然存在挑战，包括成功实施基于mRNA的疗法需要克服的技术障碍。。

Moreover, global mRNA-based vaccines and therapeutics treatment poses a significant economic burden and disrupts patients' overall well-being and QOL. Furthermore, the global mRNA-based vaccines and therapeutics market growth may be offset by failures and discontinuation of emerging therapies, unaffordable pricing, market access and reimbursement issues, and a shortage of healthcare specialists.

此外，全球基于mRNA的疫苗和治疗药物治疗带来了巨大的经济负担，并破坏了患者的整体幸福感和生活质量。此外，全球基于mRNA的疫苗和治疗剂市场的增长可能会被新兴疗法的失败和停止，无法负担的定价，市场准入和报销问题以及医疗保健专家的短缺所抵消。

In addition, the undiagnosed, unreported cases and the unawareness about the disease may also impact the global mRNA-based vaccines and therapeutics market growth..

此外，未确诊、未报告的病例以及对该疾病的不了解也可能影响全球基于mRNA的疫苗和治疗剂市场的增长。。

Global mRNA-based Vaccines and Therapeutics Market Report Metrics

全球基于mRNA的疫苗和治疗剂市场报告指标

Details

详细信息

Study Period

研究期间

2019–2032

2019–2032

Coverage

覆盖范围

7MM [the United States, the EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan].

7MM[美国、欧盟4国（德国、法国、意大利和西班牙）以及英国和日本]。

Key mRNA-based Vaccines and Therapeutics Companies

关键的基于mRNA的疫苗和治疗公司

Vertex Pharmaceuticals Incorporated, ReCode Therapeutics, ModernaTX, Inc., Merck Sharp & Dohme LLC, Remix Therapeutics, Audentes Therapeutics, Pfizer, Sirnaomics, Phoenicis Therapeutics, Astellas Pharma US, Inc., Immorna Biotherapeutics, Inc., ICON plc, Sangamo Therapeutics, 2seventy bio, Hillhurst Biopharmaceuticals, Inc., Silence Therapeutics plc, STORM Therapeutics LTD, BioNTech SE, Agomab Therapeutics NV, Alnylam Pharmaceuticals, Janssen Pharmaceutica N.V., AstraZeneca, Ocugen, Merus N.V., Sanofi, Immunomic Therapeutics, and others .

Vertex Pharmaceuticals Incorporated，ReCode Therapeutics，ModernaTX，Inc.，Merck Sharp＆Dohme LLC，Remix Therapeutics，Audentes Therapeutics，Pfizer，Sirnaomics，Phoenicis Therapeutics，Astellas Pharma US，Inc.，Immora Biotherapeutics，Inc.，ICON plc，Sangamo Therapeutics，2seventy bio，Hillhurst Biopharmaceuticals，Inc.，沉默治疗公司，风暴治疗有限公司，BioNTech SE，Agomab Therapeutics NV，Alnylam Pharmaceuticals，Janssen Pharmaceutica N.V.，AstraZeneca，Ocugen，Merus N.V.，Sanofi，Immunomic Therapeutics等。

Key Pipeline mRNA-based Vaccines and Therapeutics

基于mRNA的关键管道疫苗和疗法

VX-522, RCT1100, mRNA-4157, REM-422, scAAV9.U7.ACCA, PF-06651600, STP705, PTW-002 10, Enzalutamide, JCXH-221, BIVV003, bbT369, HBI-002, SLN124, STC-15, BNT112, AGMB-129, ALN-HSD, JNJ-55308942, AZD8701, BBV152, MCLA-158, SAR441000, ITI-1000, and others

VX-522、RCT1100、mRNA-4157、REM-422、scAAV9.U7.ACCA、PF-06651600、STP705、PTW-002 10、恩扎鲁胺、JCXH-221、BIV003、bbT369、HBI-002、SLN124、STC-15、BNT112、AGMB-129、ALN-HSD、JNJ-55308942、AZD8701、BBV152、MCLA-158、SAR441000、ITI-1000等

Scope of the Global mRNA-based Vaccines and Therapeutics Market Report

全球基于mRNA的疫苗和治疗剂市场报告的范围

Therapeutic Assessment: Global mRNA-based Vaccines and Therapeutics current marketed and emerging therapies

治疗评估：全球基于mRNA的疫苗和疗法当前上市和新兴疗法

Global mRNA-based Vaccines and Therapeutics Market Dynamics: Key Market Forecast Assumptions of Emerging Global mRNA-based Vaccines and Therapeutics Drugs and Market Outlook

全球基于mRNA的疫苗和治疗药物市场动态：新兴全球基于mRNA的疫苗和治疗药物的关键市场预测假设和市场前景

Competitive Intelligence Analysis: SWOT analysis and Market entry strategies

竞争情报分析：SWOT分析与市场进入策略

Unmet Needs, KOL's views, Analyst's views, Global mRNA-based Vaccines and Therapeutics Market Access and Reimbursement

未满足的需求、KOL的观点、分析师的观点、全球基于mRNA的疫苗和治疗剂市场准入和报销

Discover more about mRNA-based vaccines and therapeutics in development @ mRNA-based Vaccines and Therapeutics Clinical Trials

了解更多关于开发中的基于mRNA的疫苗和疗法@基于mRNA的疫苗和疗法临床试验

Table of Contents

目录

1.

1.

Global mRNA-based Vaccines and Therapeutics Key Insights

全球基于mRNA的疫苗和治疗关键见解

2.

2.

Global mRNA-based Vaccines and Therapeutics Report Introduction

全球基于mRNA的疫苗和治疗报告简介

3.

3.

Global mRNA-based Vaccines and Therapeutics Overview at a Glance

全球基于mRNA的疫苗和治疗概述

4.

4.

Global mRNA-based Vaccines and Therapeutics Executive Summary

全球基于mRNA的疫苗和疗法执行摘要

5

5

Global mRNA-based Vaccines and Therapeutics Key Events

全球基于mRNA的疫苗和治疗关键事件

6

6

Epidemiology and Market Forecast Methodology

流行病学和市场预测方法

6.

6.

Disease Background and Overview

疾病背景和概述

7.

7.

Global mRNA-based Vaccines and Therapeutics Treatment and Management

全球基于mRNA的疫苗和疗法治疗和管理

8.

8.

Global mRNA-based Vaccines and Therapeutics Guidelines

全球基于mRNA的疫苗和治疗指南

9.

9.

Global mRNA-based Vaccines and Therapeutics Epidemiology and Patient Population

全球基于mRNA的疫苗和治疗流行病学和患者人群

10.

10.

Patient Journey

患者旅程

11.

11.

Key Endpoints in Global mRNA-based Vaccines and Therapeutics

全球基于mRNA的疫苗和疗法的关键终点

12.

12.

Global mRNA-based Vaccines and Therapeutics Marketed Drugs

全球基于mRNA的疫苗和治疗药物

13.

13.

Global mRNA-based Vaccines and Therapeutics Emerging Drugs

全球基于mRNA的疫苗和治疗新兴药物

14.

14.

7MM Global mRNA-based Vaccines and Therapeutics Market Analysis

7MM全球基于mRNA的疫苗和治疗剂市场分析

15.

15.

Market Access and Reimbursement

市场准入和报销

16.

16.

KOL Views

KOL Views

17.

17.

Unmet Needs

未满足的需求

18.

18.

SWOT Analysis

SWOT分析

19.

19.

Appendix

附录

20.

20.

DelveInsight Capabilities

DelveInsight功能

21.

21.

Disclaimer

免责声明

22.

22.

About DelveInsight

关于DelveInsight

Related Reports

相关报告

Global Messenger RNA Market Market

全球信使RNA市场

Global Messenger RNA Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key global mRNA companies, including Translate Bio, AstraZeneca, Moderna, Roche (Genentech), BioNTech, Sanofi, Moderna, CureVac, Arcturus, among others..

全球信使RNA市场洞察、流行病学和市场预测-2032年报告深入了解了该疾病、历史和预测流行病学，以及市场趋势、市场驱动因素、市场障碍和全球主要mRNA公司，包括Translate Bio、AstraZeneca、Moderna、Roche（Genentech）、BioNTech、Sanofi、Moderna、CureVac、Arcturus等。。

mRNA Vaccines And Therapeutics Market

mRNA疫苗和治疗市场

mRNA Vaccines And Therapeutics Market Insights, Competitive Landscape, and Market Forecast – 2028 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key mRNA vaccines and therapeutics companies, including Pfizer Inc., BioNTech SE, Moderna, Inc., Gennova Biopharmaceuticals Limited, GSK plc., Daiichi Sankyo, Arcturus, Boehringer Ingelheim International GmbH, Ethris GmbH, CureVac SE, AIM Vaccine Corporation, Charoen Pokphand Group, Argos Therapeutics Inc., Sanofi, Kernal Biologics Inc, among others..

mRNA疫苗和治疗剂市场见解、竞争格局和市场预测-2028年报告深入了解了该疾病、历史和预测流行病学，以及市场趋势、市场驱动因素、市场障碍以及关键的mRNA疫苗和治疗剂公司，包括辉瑞公司、BioNTech SE、Moderna公司、Gennova Biopharmaceuticals Limited，葛兰素史克股份有限公司。，Daiichi Sankyo、Arcturus、勃林格殷格翰国际股份有限公司、Ethris股份有限公司、CureVac SE、AIM疫苗公司、Charoen Pokphand集团、Argos Therapeutics Inc.、赛诺菲、Kernal Biologics Inc等。。

Vaccines Market

疫苗市场

Vaccines Market Insights, Competitive Landscape, and Market Forecast – 2028 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key vaccines companies, including GlaxoSmithKline, Serum Institute of India, Bharat Biotech, AstraZeneca, Bavarian Nordic A/S, BioNTech, Sanofi, Merck & Co., Inc, Pfizer Inc, Moderna, Mitsubishi Chemical Holdings Corporation, among others..

疫苗市场见解、竞争格局和市场预测-2028年报告深入了解了该疾病、历史和预测流行病学，以及市场趋势、市场驱动因素、市场障碍和关键疫苗公司，包括葛兰素史克、印度血清研究所、巴拉特生物技术、阿斯利康、巴伐利亚北欧A/S、生物技术、赛诺菲、默克公司。，公司、辉瑞公司、摩德纳、三菱化学控股公司等。。

Cancer Vaccines Market

癌症疫苗市场

Cancer Vaccines Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cancer vaccines companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc, among others..

癌症疫苗市场洞察、流行病学和市场预测-2032年报告深入了解了市场趋势、市场驱动因素、市场障碍和关键癌症疫苗公司，包括葛兰素史克（GlaxoSmithKline）、礼来（Eli Lilly＆Company）、F.Hoffmann La Roche Ltd、AbbVie Inc等。。

About DelveInsight

关于DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve..

DelveInsight是一家专注于生命科学的领先商业顾问和市场研究公司。它通过提供全面的端到端解决方案来提高制药公司的绩效，从而为制药公司提供支持。通过我们基于订阅的平台PharmDelve，轻松访问所有医疗保健和制药市场研究报告。。

Contact UsShruti Thakur [email protected] +91-9650213330www.delveinsight.com

Contact UsShruti Thakur [email protected] +91-9650213330www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

标志https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

SOURCE DelveInsight Business Research, LLP

来源：DelveInsight Business Research，LLP